Consensus Community Health Systems, Inc.

Equities

CYH

US2036681086

Market Closed - Nyse 04:00:02 2024-07-12 pm EDT 5-day change 1st Jan Change
3.8 USD +2.43% Intraday chart for Community Health Systems, Inc. +14.80% +21.41%

Evolution of the average Target Price on Community Health Systems, Inc.

Price target over the last 5 years

History of analyst recommendation changes

dd9f0e074e7bea6a7668c1f43.mKGgVLGEMgV8zXTElpe1hw-nYdl3zcP_jl6KCdz73Yk.3dCWNtX8UFUrjwKW4a74tGuWU58n_I-K_mvyOuS9sv7V65Af4MEAQkz4RA~ecfbccfb14dfab071a642b7a50ab2433
UBS Adjusts Community Health Systems Price Target to $3.60 From $3.40, Maintains Neutral Rating MT
UBS Adjusts Community Health Systems Price Target to $3.40 From $3.10, Maintains Neutral Rating MT
Truist Raises Price Target on Community Health Systems to $3.75 From $3.25, Keeps Hold Rating MT
Oppenheimer Adjusts Community Health Systems Price Target to $4.50 From $5.50 MT
Oppenheimer Adjusts Community Health Systems Price Target to $5.50 From $6.50, Maintains Outperform Rating MT
UBS Trims Community Health Systems Price Target to $3.10 From $4, Maintains Neutral Rating MT
RBC Cuts Price Target on Community Health Systems to $6 From $7, Keeps Outperform Rating MT
Wells Fargo Adjusts Price Target on Community Health Systems to $3 From $5, Maintains Equal-Weight Rating MT
Truist Securities Adjusts Price Target on Community Health Systems to $5 From $4.50, Maintains Hold Rating MT
UBS Adjusts Community Health Systems Price Target to $4 From $3, Maintains Neutral Rating MT
Wells Fargo Adjusts Price Target on Community Health Systems to $5 From $8, Maintains Equalweight Rating MT
Credit Suisse Trims Community Health Systems' PT to $7.40 From $8.50, Lowers Estimates to Reflect Underperformance, Future Uncertainty; Keeps Neutral Rating MT
RBC Capital Adjusts Price Target on Community Health Systems to $7 From $11, Maintains Outperform Rating MT
RBC Boosts Price Target on Community Health Systems to $11 From $7, Says Guidance 'Implies Solid Margin Expansion,' Keeps Outperform Rating MT
Oppenheimer Adjusts Community Health Systems Price Target to $6.50 From $5.50, Maintains Outperform Rating MT
Oppenheimer Adjusts Community Health Systems Price Target to $5.50 From $5, Maintains Outperform Rating MT
Wells Fargo Adjusts Price Target on Community Health Systems to $4.50 From $3, Maintains Equal-Weight Rating MT
Credit Suisse Trims Community Health Systems' Price Target to $3.30 From $4, Keeps Neutral Rating MT
Credit Suisse Trims Neutral-Rated Community Health Systems' Price Target to $4 from $5 to Account for Additional Uncertainty MT
Credit Suisse Lowers Community Health Systems' Price Target to $5 from $6.50, Maintains Neutral Rating MT
UBS Adjusts Community Health Systems Price Target to $3 From $9, Maintains Neutral Rating MT
Credit Suisse Adjusts Community Health Systems' Price Target to $6.50 from $8, Keeps Neutral Rating MT
Oppenheimer Adjusts Community Health Systems Price Target to $6 From $16, Maintains Outperform Rating MT
RBC Cuts Price Target on Community Health Systems to $9 From $19 Amid 2022 Guidance Cut, Maintains Outperform Rating MT
Credit Suisse Lowers Community Health Systems' Price Target to $8 from $10.50 After Adjusting EV/EBITDA Multiple, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3.8 USD
Average target price
4.419 USD
Spread / Average Target
+16.28%
High Price Target
6 USD
Spread / Highest target
+57.89%
Low Price Target
3 USD
Spread / Lowest Target
-21.05%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Community Health Systems, Inc.

UBS
Truist Securities
Oppenheimer
RBC Capital Markets
Wells Fargo Securities
Credit Suisse
Loop Capital
BofA Securities
Citigroup
Barclays
Seaport Global Securities
Jefferies & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. CYH Stock
  4. Consensus Community Health Systems, Inc.